Presentation is loading. Please wait.

Presentation is loading. Please wait.

Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer  Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude.

Published byJemima Farmer Modified over 6 years ago

Similar presentations

Presentation on theme: "Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer  Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude."— Presentation transcript:

1 Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer 
Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude Guinet, MD, PhD, Audrey Mansuet-Lupo, MD, PhD, Antoine Rabbat, MD, Jean-François Régnard, MD, Nicolas Roche, MD, PhD, Diane Damotte, MD, PhD, Antonio Iannelli, MD, PhD, Marco Alifano, MD, PhD  The Annals of Thoracic Surgery  Volume 103, Issue 1, Pages (January 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Example of measurement of thickness of perirenal and subcutaneous fat. Measurements are carried out at left renal vein level. (A) Minimal and maximal diameters of perirenal fat at this level are measured. Psoas areas are measured at mid-L3 level by using irregular surface measurement tool of Carestream software. (B) Total psoas area is obtained by adding right and left psoas areas measured. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier survival curves in the whole population with respect to (A) body mass index (BMI) greater than 25 kg/m2 (1) versus BMI less than or equal to 25 kg/m2 (2) (p = 0.015), (B) total psoas area greater than 33rd percentile (1) versus less than or equal to 33rd percentile (2) (p = 0.029), and (C) serum C-reactive protein (CRP) levels less than or equal to 20 mg/L (1) versus greater than 20 mg/L (2) (p = 0.017). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival curves in patients who survived operation with respect to (A) body mass index greater than 25 kg/m2 (1) versus less than or equal to 25 kg/m2 (2) (p = 0.037), (B) total psoas area greater than 33rd percentile (1) versus less than or equal to 33rd percentile (2) (p = 0.048), and (C) serum C-reactive protein (CRP) levels less than or equal to 20 mg/L (1) versus greater than 20 mg/L (2) (p = 0.015). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer  Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude."

Similar presentations

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy  Michel E. van Genderen, BS, Alexandre.

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy  Michel E. van Genderen, BS, Alexandre.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.

Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer  Marco Alifano, MD, PhD, Pierre.
C-Reactive Protein Predicts Acute Kidney Injury and Death After Coronary Artery Bypass Grafting  Seung Seok Han, MD, PhD, Dong Ki Kim, MD, PhD, Sejoong.

C-Reactive Protein Predicts Acute Kidney Injury and Death After Coronary Artery Bypass Grafting  Seung Seok Han, MD, PhD, Dong Ki Kim, MD, PhD, Sejoong.
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Laura Harvey, MD, Christopher Holley, MD, Samit S

Laura Harvey, MD, Christopher Holley, MD, Samit S
Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Abducens Nerve Palsy After Schwannoma Resection

Abducens Nerve Palsy After Schwannoma Resection
Which Arterial Conduit

Which Arterial Conduit
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.

Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.
David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 

David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Less Is More in Post Pediatric Heart Transplant Care

Less Is More in Post Pediatric Heart Transplant Care
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Similar presentations

Ads by Google